New pediatric trauma study—first in the nation—to examine whether medication that stops bleeding in adults works in severely-injured children. University of Utah Health and Intermountain Primary Children’s Hospital are jointly participating in the nation’s first-ever pediatric multi-center clinical trial of a medication to determine if it is effective in stopping bleeding in children who experience severe traumatic injuries.

Researchers receive academic appointments from Intermountain Healthcare. Intermountain extended academic appointments to 23 researchers, enhancing the experience of caregivers and supporting research systemwide to ultimately deliver better care to patients. The first three cohorts were appointed in late 2019 and represent 15 research areas, giving investigators an academic identity at Intermountain, which was previously not available.

IRMF grants fueling innovation. Sean Esplin, MD, and Sarah Majercik, MD, received grant funding approval from the Intermountain Research and Medical Foundation as it announced its 2019 fourth quarter research grant approvals for innovative research projects.

Intermountain researchers selected to University of Utah scholars’ program. Two Intermountain caregivers, Kate Minick and Andrew Knighton, have recently been named to the Vice President’s Clinical & Translational Research Scholars Program at the University of Utah. Kate Minick, PhD, DPT, of Rehabilitation Services, and Andrew Knighton, PhD, CPA, of the Healthcare Delivery Institute, were selected for 2020-2021.

New Intermountain study aims to determine the most effective method to identify people at risk for heart disease before they ever develop problems. Researchers from the Intermountain Healthcare Heart Institute are launching one of the largest and most ambitious research initiatives ever undertaken in the state of Utah to test a new standard of care to better identify and treat people at risk of having a heart attack—and to potentially stop it before they ever have one.